Computational chemistry

AI and robotics
#Artificial intelligence (AI) #Computational chemistry #Deep Origin #Lymphoma #Oncology

AI validates molecular glue compound that kills lymphoma cells

Deep Origin’s docking and molecular dynamics (MD) simulations have successfully rationalised researchers’ work identifying a potent compound to switch on cell-death programmes in diffuse large B cell lymphoma (DLBCL).  The study was led by researchers at Stanford University and the University of Texas MD Anderson Cancer Center. … Read More

#Cancer Research #News

#Artificial intelligence (AI) #Computational chemistry #Drug discovery #Machine learning

AI can’t replace scientists, but here’s how it can assist them

Dr Paul Finn, Chief Scientific Officer at Oxford Drug Design, explores the current use of AI in drug discovery and where the technology falls short.  Nobody can have failed to notice the rapid entry of AI into many aspects of our daily lives; as a source of information and news,… Read More

#Exclusive Content

Water molecules
#Cancer research #Computational chemistry #Oncology #The Institute of Cancer Research

Study reveals how water influences cancer drug potency

Researchers have demonstrated how computational simulations can unravel the complex role of water molecules in drug binding.  The study focused on B-cell lymphoma 6 (BCL6), a protein implicated in several cancers. Using advanced computational techniques, the team showed how subtle changes in drug molecules can disrupt or… Read More

#Cancer Research #Editor's Choice #News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Transforming drug discovery with AI and digital labs: Last chance to register

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: Evaluate billions of compounds in record time

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

Digital technology concept
#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: AI and digital workflows reshape pharmaceutical R&D

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: How is AI revolutionising drug discovery?

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

Digital pathology
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: The impact of digital pathology and AI on drug discovery

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: Transforming drug discovery with AI and digital labs

A new free to attend webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning

Transforming drug discovery with AI and digital labs

In this FREE TO ATTEND webinar, hosted by DDW and supported by Sapio Sciences, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational methods, AI, and machine learning are revolutionising drug discovery. Dr Kumar highlights how Schrödinger’s physics-based simulations and Free Energy… Read More

Webinar date:
Supported by Sapio Sciences
#Webinars

Scientist using a laptop
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: Hear from companies at the forefront of digital pathology

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

Histology slides
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: Biopharma and the shift to computational pathology

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

Computer in laboratory
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: How pathology AI is transforming biopharma R&D

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

Digital pathology
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology #Webinar

Webinar: The strategic power of pathology and AI for biopharma R&D

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#News

Digital pathology
#Artificial intelligence (AI) #Biopharma #Computational chemistry #Events #Pathology

Rewiring drug development: The strategic power of pathology and AI for biopharma R&D

Digital pathology and AI are fundamentally transforming how biopharma companies discover, develop, and deliver life-changing medicines. As a result, today’s leaders aren’t debating whether to invest in digital pathology—they’re racing to scale it, unlocking faster breakthroughs, smarter clinical trials, and broader patient access to next-generation therapies. Organisations that move quickly… Read More

Webinar date:
Sponsored by Proscia
#Webinars

#Artificial intelligence (AI) #Computational chemistry #Data science #Lab technology #Machine learning

Five potential problems with overhyping AI in drug discovery

Lucy Sabin, Postdoctoral Researcher at the University of Sheffield’s Information School reports on a study that examines how computational and medicinal chemists in drug discovery feel about AI. Whilst they are positive about AI methods in the field, they‘re calling for more realistic expectations. A growing number of pharmaceutical companies… Read More

#Exclusive Content